SRPT

Sarepta Therapeutics (SRPT), a Health Care sector equity, appears in the congressional disclosure record with three distinct members having filed a combined seven trades between January 2023 and April 2025, reflecting modest and intermittent activity in the name. The balance of those transactions runs slightly toward the sell side, with four sales against three purchases, and the most active filers by trade count are Daniel Goldman, Josh Gottheimer, and Gil Cisneros. No bipartisan co-trading clusters are recorded for this ticker. Separately, three executive-branch officials have disclosed five transactions in the same security in independent public filings, though the closest pairing of congressional and executive purchases falls 798 days apart, well outside any proximity window of overlap.